Clinical and serological predictors of post COVID-19 condition–findings from a Canadian prospective cohort study

• Erin Collins,
• Yannick Galipeau,
• Corey Arnold,
• Anne Bhéreur,
• Ronald Booth,
• Arianne C. Buchan,
• Arianne C. Buchan,
• Curtis Cooper,
• Curtis Cooper,
• Curtis Cooper,
• Curtis Cooper,
• Curtis Cooper,
• Angela M. Crawley,
• Angela M. Crawley,
• Angela M. Crawley,
• Angela M. Crawley,
• Pauline S. McCluskie,
• Michaeline McGuinty,
• Michaeline McGuinty,
• Martin Pelchat,
• Lynda Rocheleau,
• Raphael Saginur,
• Raphael Saginur,
• Raphael Saginur,
• Chris Gravel,
• Chris Gravel,
• Chris Gravel,
• Steven Hawken,
• Steven Hawken,
• Marc-André Langlois,
• Marc-André Langlois,
• Marc-André Langlois,
• Julian Little,
• Julian Little,
• Julian Little,
• Julian Little

Affiliations

Erin Collins

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Yannick Galipeau

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada

Corey Arnold

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada

Anne Bhéreur

Faculty of Medicine, University of Montreal, Montreal, QC, Canada

Ronald Booth

Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Arianne C. Buchan

Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Arianne C. Buchan

Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Curtis Cooper

Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Curtis Cooper

Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Curtis Cooper

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Curtis Cooper

Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Curtis Cooper

Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, ON, Canada

Angela M. Crawley

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada

Angela M. Crawley

Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Angela M. Crawley

Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, ON, Canada

Angela M. Crawley

Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Pauline S. McCluskie

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada

Michaeline McGuinty

Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Michaeline McGuinty

Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Martin Pelchat

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada

Lynda Rocheleau

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada

Raphael Saginur

Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Raphael Saginur

Division of Infectious Diseases, Department of Medicine, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Raphael Saginur

0Ottawa Health Science Network Research Ethics Board (OHSN-REB), Ottawa Hospital Research Institute, Ottawa, ON, Canada

Chris Gravel

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Chris Gravel

1Department of Mathematics and Statistics, University of Ottawa, Ottawa, ON, Canada

Chris Gravel

2Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada

Steven Hawken

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Steven Hawken

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Marc-André Langlois

Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada

Marc-André Langlois

Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Marc-André Langlois

Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, ON, Canada

Julian Little

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Julian Little

Clinical Epidemiology, Ottawa Hospital Research Institute, Ottawa, ON, Canada

Julian Little

Coronavirus Variants Rapid Response Network (CoVaRR-Net), Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Julian Little

3The Knowledge Synthesis and Application Unit (KSAU), University of Ottawa, Ottawa, ON, Canada